| Hans-Günter Meyer-Thompson | Legal
What will happen to Mundipharma Korea as its headquarters sell out foreign offshoots?
What will happen to Mundipharma Korea as its headquarters sell out foreign offshoots?
The domestic pharma industry is paying attention to whether Mundipharma Korea will be included in the series of foreign branch sell-offs by its headquarter office, Purdue Pharma. (Korea Biomedical Review, Korea, 06.01.2023)
https://www.koreabiomed.com/news/articleView.html?idxno=20188